Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

BACKGROUND: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodcock, Ashley, Bateman, Eric D, Busse, William W, Lötvall, Jan, Snowise, Neil G, Forth, Richard, Jacques, Loretta, Haumann, Brett, Bleecker, Eugene R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217852/
https://www.ncbi.nlm.nih.gov/pubmed/21977941
http://dx.doi.org/10.1186/1465-9921-12-132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217852/
https://www.ncbi.nlm.nih.gov/pubmed/21977941
http://dx.doi.org/10.1186/1465-9921-12-132

Ejemplares similares